
Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension
New Delhi: Global pharma major, Lupin Limited (Lupin) today announced that it has received tentative approval from the United States Food and Drug…
Be Ahead With Economy And Policy Updates

New Delhi: Global pharma major, Lupin Limited (Lupin) today announced that it has received tentative approval from the United States Food and Drug…

New Delhi: Sun Pharmaceutical Industries Limited and LIB Therapeutics Inc — Sun Pharma, LIB Therapeutics Ink Global Licensing Deal for Lerodalcibep

New Delhi: Jagsonpal Pharmaceuticals Ltd — Jagsonpal Pharmaceuticals to Acquire Wellness Portfolio of Group Pharmaceuticals

Vyara, (Tapi): Torrent Group’s UNM Foundation today announced the inauguration of a 317-bed redeveloped transitional facility and also laid the Foundation…

New Delhi: Fredun Pharmaceuticals Limited has acquired a 26% stake in Goodman Vetcare Private Limited marking a strategic step towards strengthening its…

New Delhi: Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch1 of Calcium Gluconate Injection USP, 1,000 mg/10 mL (100 mg/mL) Single-Dose…

Mumbai: Global pharma major Lupin Limited (Lupin) today announced that it has received the final approval from the United States Food and Drug Administration…

Apollo Hospitals Announces Strong Q1 FY27 Performance and Key Strategic Milestones — Apollo Hospitals Announces Strong Q1 FY27 Performance and Key Strategic…

Lupin Announces Q1 FY2027 Results — Lupin Announces Q1 FY2027 Results

Ahmedabad: Torrent Pharmaceuticals Limited (“Company”) today announced its financial results for the first quarter of FY27 — Torrent Pharma Announces Q1 FY27…
Newsletter

Transrail Delivers 32% YoY Revenue Growth in Q2 FY27


India’s rapid renewables growth is strengthening its role in global energy markets, IEA report finds

Essar Renewables Signs 300 MW FDRE PPA with NHPC

SPML Infra Secures ₹186.41 Crore Orders from Power Grid

Equitas Small Finance Bank Appoints Balaji Nuthalapadi as Interim CEO